ClinicalTrials.Veeva

Menu

Immune Response of Haemodialysis Patients Post Covid-19 Vaccination

P

Penang Hospital, Malaysia

Status

Unknown

Conditions

Immune Response Post Covid 19 Vaccination

Study type

Observational

Funder types

Other

Identifiers

NCT04872751
NMRR-21-634-59445

Details and patient eligibility

About

The purpose of this study is to assess immune response of end stage renal failure patients after Covid 19 vaccination

Enrollment

425 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ESRF patient on hemodialysis who are eligible for the goverment Covid 19 vaccination programme
  • 18 years old and above
  • consented to join the study

Exclusion criteria

  • patient who refused to be vaccinated
  • patient who deemed unsuitable for Covid vaccination

Trial contacts and locations

1

Loading...

Central trial contact

XueFang Tan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems